Retinoblastoma future or investigational therapies

Jump to: navigation, search

Retinoblastoma Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Retinoblastoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Retinoblastoma future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Retinoblastoma future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Retinoblastoma future or investigational therapies

CDC on Retinoblastoma future or investigational therapies

Retinoblastoma future or investigational therapies in the news

Blogs on Retinoblastoma future or investigational therapies

Directions to Hospitals Treating Retinoblastoma

Risk calculators and risk factors for Retinoblastoma future or investigational therapies

Overview

Patients who have been treated with radiation are at higher risk for secondary tumors in the field of treatment.[1]


References


Linked-in.jpg